A systematic review of patient-reported outcome instruments of dermatologic adverse events associated with targeted cancer therapies

Impact of Dermatologic Adverse Events on Quality of Life in 283 Cancer Patients: A Questionnaire Study in a Dermatology Referral Clinic

(2013) Alyx C. Rosen et al.   AMERICAN JOURNAL OF CLINICAL DERMATOLOGY

Role of sunitinib and SU12662 on dermatological toxicities in metastatic renal cell carcinoma patients: in vitro, in vivo, and outcomes investigation

(2013) Yi Ling Teo et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Experiences with the FACT-EGFRI-18 instrument in EGFRI-associated mucocutaneous adverse events

(2013) Christine B. Boers-Doets et al.   SUPPORTIVE CARE IN CANCER

Treatment of Metastatic Colorectal Cancer with Cetuximab: Influence on the Quality of Life.

(2013) K. Unger et al.   ZEITSCHRIFT FUR GASTROENTEROLOGIE

Dermatology Life Quality Index (DLQI): A Paradigm Shift to Patient-Centered Outcomes

(2012) Andrew Y. Finlay et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Grading dermatologic adverse events of cancer treatments: The Common Terminology Criteria for Adverse Events Version 4.0

(2012) Alice P. Chen et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

The development of a Functional Assessment of Cancer Therapy (FACT) questionnaire to assess dermatologic symptoms associated with epidermal growth factor receptor inhibitors (FACT-EGFRI-18)

(2012) Lynne I. Wagner et al.   SUPPORTIVE CARE IN CANCER

Beyond the FDA PRO Guidance: Steps toward Integrating Meaningful Patient-Reported Outcomes into Regulatory Trials and US Drug Labels

(2012) Ethan Basch   VALUE IN HEALTH

The Skindex Instruments to Measure the Effects of Skin Disease on Quality of Life

(2011) Mary-Margaret Chren   DERMATOLOGIC CLINICS

HFS-14, a Specific Quality of Life Scale Developed for Patients Suffering from Hand-Foot Syndrome

(2011) V. Sibaud et al.   ONCOLOGIST

PCN82 HFS 14: A SPECIFIC QUALITY OF LIFE INSTRUMENT FOR PATIENTS WITH HAND-FOOT SYNDROME

(2011) C Taieb et al.   VALUE IN HEALTH

Effects of epidermal growth factor receptor inhibitor-induced dermatologic toxicities on quality of life

(2010) Smita S. Joshi et al.   CANCER

Quality of life in colon cancer patients with skin side effects: preliminary results from a monocentric cross sectional study

(2010) Federica Andreis et al.   Health and Quality of Life Outcomes

Skin Toxicity Evaluation Protocol With Panitumumab (STEPP), a Phase II, Open-Label, Randomized Trial Evaluating the Impact of a Pre-Emptive Skin Treatment Regimen on Skin Toxicities and Quality of Life in Patients With Metastatic Colorectal Cancer

(2010) Mario E. Lacouture et al.   JOURNAL OF CLINICAL ONCOLOGY

Cutaneous side-effects in patients on long-term treatment with epidermal growth factor receptor inhibitors

(2009) A. Osio et al.   BRITISH JOURNAL OF DERMATOLOGY

The Science behind Quality-of-Life Measurement: A Primer for Plastic Surgeons

(2009) Stefan J. Cano et al.   PLASTIC AND RECONSTRUCTIVE SURGERY

Tetracycline to prevent epidermal growth factor receptor inhibitor-induced skin rashes

(2008) Aminah Jatoi et al.   CANCER